Diagnostic Molecular Pathology Conference
April 13-14, 2015 | DoubleTree Hotel | Rochester, MN
Diagnostic Molecular Pathology is currently regarded as a fundamental element of surgical pathology. Excellent oncologic care requires that practicing surgical pathologists understand molecular testing platforms, results, and clinical significance. This comprehensive case-based conference will prepare its attendees for both common and uncommon clinical scenarios where molecular testing should be applied in a cost- and time-effective manner.
Subspecialties of anatomic pathology covered in this two-day conference include head and neck pathology, gastrointestinal pathology, lung pathology, breast pathology, neuropathology, genitourinary pathology, gynecologic pathology, and hematopathology.
This program is designed for practicing surgical and molecular pathologists, and other medical laboratory scientists or physicians interested in enhancing their delivery of care.
- Identify clinical scenarios where molecular testing is appropriate—and inappropriate
- Discuss fundamental features of molecular testing platforms
- Interpret molecular test results
- Explain the clinical significance of molecular test results
Joaquin Garcia, M.D.
Sarah Kerr, M.D.
Benjamin Kipp, Ph.D.
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine designates this live activity for a maximum of 13 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development) must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.
National Physician Payment Transparency Program
Mayo Clinic College of Medicine complies with the requirements of the National Physician Payment Transparency Program OPEN PAYMENTS (Physician Payments Sunshine Act).